PT932613E - Expressao de bloqueio de factoes de virulencia em s. aureus - Google Patents

Expressao de bloqueio de factoes de virulencia em s. aureus

Info

Publication number
PT932613E
PT932613E PT97927727T PT97927727T PT932613E PT 932613 E PT932613 E PT 932613E PT 97927727 T PT97927727 T PT 97927727T PT 97927727 T PT97927727 T PT 97927727T PT 932613 E PT932613 E PT 932613E
Authority
PT
Portugal
Prior art keywords
aureus
expression
virulence
facts
blocking
Prior art date
Application number
PT97927727T
Other languages
English (en)
Inventor
Richard P Novick
Ji Guangyong
Beavis Ronald
Original Assignee
Univ New York
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ New York filed Critical Univ New York
Publication of PT932613E publication Critical patent/PT932613E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
    • C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Chemical And Physical Treatments For Wood And The Like (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Electrotherapy Devices (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)
  • Heat Treatment Of Steel (AREA)
  • Air Conditioning Control Device (AREA)
  • Control Of Combustion (AREA)
PT97927727T 1996-05-22 1997-05-22 Expressao de bloqueio de factoes de virulencia em s. aureus PT932613E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US65122696A 1996-05-22 1996-05-22

Publications (1)

Publication Number Publication Date
PT932613E true PT932613E (pt) 2005-06-30

Family

ID=24612055

Family Applications (1)

Application Number Title Priority Date Filing Date
PT97927727T PT932613E (pt) 1996-05-22 1997-05-22 Expressao de bloqueio de factoes de virulencia em s. aureus

Country Status (8)

Country Link
EP (1) EP0932613B1 (pt)
JP (1) JP2000511537A (pt)
AT (1) ATE290548T1 (pt)
AU (1) AU735283B2 (pt)
CA (1) CA2256465A1 (pt)
DE (1) DE69732709T2 (pt)
PT (1) PT932613E (pt)
WO (1) WO1997044349A1 (pt)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9724859D0 (en) * 1997-11-26 1998-01-21 Univ Nottingham Compounds and their use as antibacterial agents
US6291431B1 (en) 1997-12-19 2001-09-18 Panorama Research Methods and compositions for the treatment and prevention of Staphylococcal infections
US7534857B2 (en) 1997-12-19 2009-05-19 Centegen, Inc. Methods and compositions for the treatment and prevention of staphylococcal infections
US7323179B2 (en) 1997-12-19 2008-01-29 Naomi Balaban Methods and compositions for the treatment and prevention of Staphylococcus and other bacterial infections
US6337385B1 (en) 1998-06-24 2002-01-08 The Rockefeller University Staphylococcus peptides for bacterial interference
EP1090034A2 (en) * 1998-06-24 2001-04-11 The Rockefeller University Novel staphylococcus peptides for bacterial interference
EP1188831B1 (en) * 1998-09-15 2007-12-05 Naomi Balaban Target of RNAIII activating protein (TRAP)
EP1862549A3 (en) 1998-09-15 2008-02-13 Naomi Balaban Target of RNAIII activating protein (TRAP)
US6747129B1 (en) 1998-09-15 2004-06-08 The Regents Of The University Of California Target of RNAIII activating protein(TRAP)
WO2001058471A2 (en) * 2000-02-10 2001-08-16 Intermune, Inc. Novel amino acid and peptide inhibitors of staphylococcus virulence
AU2001234147A1 (en) * 2000-02-23 2001-09-03 Kureha Chemical Industry Co. Ltd. Plant growth promoters and method of promoting plant growth
US7824691B2 (en) 2005-04-04 2010-11-02 Centegen, Inc. Use of RIP in treating staphylococcus aureus infections
KR101557173B1 (ko) * 2007-10-25 2015-10-05 더 스크립스 리서치 인스티튜트 박테리아에서의 쿼럼 센싱의 항체 매개성 파괴
ES2682595T3 (es) * 2015-03-23 2018-09-21 Eberhard Karls Universität Tübingen Nuevo compuesto antiinfeccioso
US10821167B2 (en) * 2016-02-02 2020-11-03 Unm Rainforest Innovations VLP-based vaccines for targeting Staphylococcus aureus secreted virulence factors
CA3072772A1 (en) * 2017-08-31 2019-03-07 The Regents Of The University Of California Molecular bacteriotherapy to control skin enzymatic activity
KR102199062B1 (ko) * 2019-09-27 2021-01-06 코스맥스 주식회사 스타필로코커스 자일로서스 st-10 균주 및 그의 피부 상태 개선 용도
KR102195998B1 (ko) * 2019-09-27 2020-12-29 코스맥스 주식회사 스타필로코커스 시뮬란스 st-9 균주 및 그의 피부 상태 개선 용도
KR102286075B1 (ko) * 2019-09-27 2021-08-05 코스맥스 주식회사 스타필로코커스 렌투스 st-2 균주 및 그의 피부 상태 개선 용도

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3825995A (en) * 1994-10-04 1996-04-26 New York University Blocking expression of virulence factors in s. aureus

Also Published As

Publication number Publication date
AU3211797A (en) 1997-12-09
DE69732709D1 (de) 2005-04-14
CA2256465A1 (en) 1997-11-27
ATE290548T1 (de) 2005-03-15
EP0932613A1 (en) 1999-08-04
JP2000511537A (ja) 2000-09-05
AU735283B2 (en) 2001-07-05
DE69732709T2 (de) 2006-06-29
EP0932613B1 (en) 2005-03-09
WO1997044349A1 (en) 1997-11-27
EP0932613A4 (en) 2002-01-09

Similar Documents

Publication Publication Date Title
PT932613E (pt) Expressao de bloqueio de factoes de virulencia em s. aureus
ID21526A (id) 4-hidroksiquinolin-3-karboksamida dan hidrazida sebagai bahan anti-virus
LU91928I2 (fr) Ipilimumab et ses dérivés pharmaceutiquement acceptables (YERVOY®)
BR9502707A (pt) Composto composição farmacêutica e método para o tratamento de uma afecção
DE60137337D1 (de) Vorbeugende und therapeutsche monoklonale antikörper gegen vacciniavirusantigene
PE14199A1 (es) Agonistas de 5-ht1f
PT1056454E (pt) Utilizacao de compostos macrolido para o tratamento do glaucoma
ATE335499T1 (de) Zusammensetzungen zur behandlung von staphylococcus aureus infektionen
DE60041753D1 (de) Arzneimittel zur behandlung von c. pneumoniae infektionen
BR9708114A (pt) Análogos xantona para o tratamento de doenças infecciosas.
DE69938935D1 (de) Zyklische conotoxin-peptide
AU3902299A (en) Methods of treating microbial infection and therapeutic formulations therefor
PT934065E (pt) Compostos farmaceuticos
DE69729183T2 (de) Als entzündungshemmende mittel nützliche dihydrobenzofurane und verwandte verbindungen
RS50148B (sr) Upotreba docetaksela za lečenje hepatoćelijskog karcinoma
MXPA00007394A (es) Compuestos, composiciones y metodos para tratar o evitar infeccion de neumovirus y enfermedades asociadas.
BR0111785A (pt) Composições e métodos para tratamento de candidìase
DK1073436T3 (da) Forbedret fremgangsmåde til udryddelse af helicobacter pylori
WO2000063386A3 (en) Prevention, diagnosis and treatment of lyme disease
EA200101171A1 (ru) Способ лечения инфекций, вызванных streptococcus pneumoniae
DE60024977D1 (de) Klonierung und expression von haemophilus somnus transferrin-bindenden proteinen
NZ505085A (en) Pharmaceutical compositions comprising bipapcitide monocarboxylate and/or bipapcitide dicarboxylate for imaging and treating thrombi
WO1998014567A3 (en) Methods and compositions for inhibiting bacterial growth
ATE401349T1 (de) Monoklonale antikörper gegen das map-protein und verfahren zu dessen anwendung bei der behandlung bzw. prävention von infektionen
SE9902674D0 (sv) New composition